Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Heart, Lung, and Blood Institute (NHLBI)
With
National Institutes of Health (NIH)
The current observational trial, Follow-Up Study ((FUS) II includes enhanced neuropsychological, brain, cardiac, and pulmonary evaluations for this very well characterized cohort of subjects. Measures of spleen and renal function and markers of DNA damage will continue to be collected. Assessment of other target organs in sickle cell disease including pulmonary and cardiac function will be performed in addition to evaluation of developmental aspects of sickle cell disease (SCD) and potential HU toxicity.
Age
2–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All subjects enrolled in the BABY HUG Follow-Up I Study who participated for at least 24 months are eligible for the Follow-Up Study II